(Q43923731)

English

Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy

scientific article published in April 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

Margaret L MacMillan

1

object named as

Margaret L MacMillan

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Jesse L Goodman

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Todd E DeFor

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Daniel J Weisdorf

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

112

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

369-379

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

Role of granulocyte colony-stimulating factor as adjunct therapy for septicemia in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

Granulocyte Colony‐Stimulating Factor Administered In Vivo Augments Neutrophil‐Mediated Activity against Opportunistic Fungal Pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

G-CSF stimulated donor granulocyte collections for prophylaxis and therapy of neutropenic sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901127-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9343(01)01127-5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43923731&oldid=2104419990"